Evidence map›Paper›PMID 33936518›Full record

ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2020

Alexandra Zingg, Deevakar Rogith, Jerrie S Refuerzo, Sahiti Myneni

Open access · greenAbstract read
In one paragraph

Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alexandra ZinggUniversity of Texas Health Science Center at Houston, School of Biomedical Informatics, Houston, Texas, USA.
Deevakar RogithUniversity of Texas Health Science Center at Houston, School of Biomedical Informatics, Houston, Texas, USA.
Jerrie S RefuerzoUT Physician's Women's Center, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Sahiti MyneniUniversity of Texas Health Science Center at Houston, School of Biomedical Informatics, Houston, Texas, USA.
The University of Texas Health Science Center at Houston · US

Funding

Pragmatics to Reveal Intention in Social Media (PRISM) for Health PromotionR01LM012974 · NLM · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MYNENI, SAHITI · 2019 to 2022
$1.5M
NLM NIH HHS R01 LM012974
6 · The paper itself

Abstract

Digital health technologies offer unique opportunities to improve health outcomes for mental health conditions such as peripartum depression (PPD), a disorder that affects approximately 10-15% of women in the U.S. every year. In this paper, we present the adaption of a digital technology development framework, Digilego, in the context of PPD. Methods include mapping of the Behavior Intervention Technology (BIT) model and the Patient Engagement Framework (PEF) to translate patient needs captured through focus groups. This informs formative development and implementation of digital health features for optimal patient engagement in PPD screening and management. Results show an array ofPPD-specific Digilego blocks ("My Diary", "Mom Talk", "My Care", "Library", "How am I doing today?"). Initial evaluation results from comparative market analysis indicate that our proposed platform offers advantageous technology aspects. Limitations and future work in areas of interdisciplinary care coordination and patient engagement optimization are discussed.

Indexed as

DepressionPeripartum PeriodAdultFemaleFocus GroupsHumansMass ScreeningPatient Participation

Identifiers

PMID33936518
PMCPMC8075464
OpenAlexW3158592316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.